Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MRI Safety Guidance Outlines Testing, Labeling Terms For Passive Implants

This article was originally published in The Gray Sheet

Executive Summary

An Aug. 21 FDA guidance document on device safety for magnetic resonance imaging offers makers of passive implants three options for describing their products in labeling - MR safe, MR unsafe or MR conditional

You may also be interested in...



FDA Updates Guidance On Labeling Passive Implants For MRI

The agency has revised a 2008 guidance to spell out when it is OK to state in labeling that a non-electronic, or passive, implant has not been evaluated for safe use in a magnetic resonance environment, among other clarifications.

FDA Working On MRI-Compatibility Standards For Active Device Implants

Creating standards to determine when companies can claim that "active" implantable devices are safe to use with magnetic resonance imaging is a key focus of CDRH's Office of Science and Engineering Laboratories, says acting director Laurence Grossman

FDA Working On MRI-Compatibility Standards For Active Device Implants

Creating standards to determine when companies can claim that "active" implantable devices are safe to use with magnetic resonance imaging is a key focus of CDRH's Office of Science and Engineering Laboratories, says acting director Laurence Grossman

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel